New Findings: Blood and Ocular Biomarkers for Alzheimer’s Detection A groundbreaking study published in Alzheimer’s & Dementia sheds light on the future of Alzheimer’s diagnostics. The research suggests that blood biomarkers will likely become the […]
Tag: Alzheimer's Drug Discovery Foundation
New Investment from the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Leads Efforts to Develop Standardization Materials for Leading Diagnostic Biomarker
The DxA partners with Dr’s Henrik Zetterberg and Nicholas Ashton to create critical standardized reference materials for leading Alzheimer’s blood biomarker, p-Tau217, to ensure consistency across global research and clinical settings NEW YORK, Nov. 14, […]